Frontlight ResearchEarly access
CompletedNo phase
Risk of Aspergillus Infection in Patients With Chronic Lung Disease
Key facts
- Who runs it
- Lin Chen
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 209 people enrolled
- Started
- 1 Jul 2022
- Ended
- 31 Jan 2024
- Type of study
- Observational, 2 groups
- Record updated
- 23 April 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Age : at least 18 years old
- Imageological examination : Patients who complete high-resolution computed tomography (HRCT) images of the chest
- Serological examination : Patients who complete serological test results, including serum aspergillus specific IgG antibody, serum aspergillus IgM antibody and GM antigen detection
Who cannot take part
- immunodeficiency conditions : Patients diagnosed with HIV infection, hematological malignancies, and autoimmune diseases
- Critically ill patients : Those who require mechanical ventilation in the ICU and have established various types of cardiopulmonary bypass
- Inadequate Clinical Data: Inability to provide reliable diagnostic measurements or insufficient clinical information
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Large doses of systemic corticosteroids ,severe lung tissue damage and longer COPD diagnosis may increase the risk of IPA in patients with chronic structural lung disease. By comparing the risk factors of aspergillus colonization group and aspergillus infection group, the main risk factors of aspergillus pneumonia were determined.
The 2 groups in the trial
- Aspergillus pneumonia group
According to diagnostic criteria , patients diagnosed with IPA and CPA and were assigned to the Aspergillosis pneumonia group
- control group
The remaining patients without IPA and CPA were included in the Aspergillus colonization group
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Risk of Aspergillus Infection in Patients With Chronic Structural Lung Disease
- Publications
- Non-invasive monitoring of Aspergillus infections in chronic lung disease patients: a combined serology and HRCT imaging approach.Frontiers in cellular and infection microbiology, 2025
- Record updated
- 23 April 2024